Andrew Mark Pardoll

Professor

1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrew Mark Pardoll is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • Neoadjuvant checkpoint blockade for cancer immunotherapy

    Topalian, S. L., Taube, J. M. & Pardoll, D. M., Jan 31 2020, In : Science. 367, 6477, eaax0182.

    Research output: Contribution to journalReview article

  • Pan-tumor pathologic scoring of response to PD-(L)1 blockade

    Stein, J. E., Lipson, E. J., Cottrell, T. R., Forde, P. M., Anders, R. A., Cimino-Mathews, A., Thompson, E. D., Allaf, M. E., Yarchoan, M., Feliciano, J., Wang, H., Jaffee, E. M., Pardoll, D. M., Topalian, S. L. & Taube, J. M., Feb 1 2020, In : Clinical Cancer Research. 26, 3, p. 545-551 7 p.

    Research output: Contribution to journalReview article

  • Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma

    Windon, M. J., D'Souza, G., Waterboer, T., Rooper, L., Westra, W. H., Troy, T., Pardoll, D., Tan, M., Yavvari, S., Kiess, A. P., Miles, B., Mydlarz, W. K., Ha, P. K., Bender, N., Eisele, D. W. & Fakhry, C., Jan 1 2020, (Accepted/In press) In : Head and Neck.

    Research output: Contribution to journalArticle

  • A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy

    Wolf, M. T., Ganguly, S., Wang, T. L., Anderson, C. W., Sadtler, K., Narain, R., Cherry, C., Parrillo, A. J., Park, B. V., Wang, G., Pan, F., Sukumar, S., Pardoll, D. M. & Elisseeff, J. H., Jan 30 2019, In : Science Translational Medicine. 11, 477, aat7973.

    Research output: Contribution to journalArticle